atezolizumab,bevacizumab
roche
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'atezotribe', 'atezo']
 check our poster by ale boccaccino at #asco22! io score by oncocyte applied to atezotribe trial to predict benefit from the addition of atezo to folfoxiri/bev in mcrc. promising result for pmmr io+ 
GONO Foundation is a no-profit group of Italian Investigators committed to design & conduct of academic clinical trials in oncology